General Archive
-
Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type II
-
Phase II Study of a Novel Vitamin Metabolite (CoA-Z) for Pantothenate Kinase Associated Neurodegeneration
-
DefINe: A trial to test the use of deferiprone in people with neuroferritinopathy
-
The TIARA trial: Investigating a new treatment for a life-threatening blood disorder
The TIARA trial: Investigating a new treatment for a life-threatening blood disorder A collaboration with the Aplastic Anaemia Trust to…
-
Innovation Hubs for Gene Therapy: A national network to transform gene therapy research
Innovation Hubs for Gene Therapy: A national network to transform gene therapy research Our partnership with the Medical Research Council…
-
GOSH and UCL: Co-funding a new blood test to detect a deadly heart condition in children
GOSH and UCL: Co-funding a new blood test to detect a deadly heart condition in children Researchers at UCL (University…
-
GOSH: A partnership to increase access to gene therapies for children with rare diseases
GOSH: A partnership to increase access to gene therapies for children with rare diseases We are collaborating with Great Ormond…
-
Funding: Partnering with Great Ormond Street Hospital Charity (GOSH Charity) to deliver translational research accelerator grants
Funding: Partnering with Great Ormond Street Hospital Charity (GOSH Charity) to deliver research grants for paediatric rare diseases With GOSH…
-
News releasesPromising results in clinical trial gives hope to patients with blood disorder
A trial for a cutting-edge cell therapy that could become the first ever treatment for the rare, life-threatening blood disorder…
-
RAREfest 2024
About the event RAREfest is a unique science, technology, community and arts festival run by Cambridge Rare Disease Network (CamRARE).…
-
Getting Cilia Moving
About the event LifeArc are pleased to support this that event will bring together all stakeholders to discuss innovative approaches…
-
News releasesLifeArc funds innovative rare liver disease clinical trial
The first patient has been recruited for the FARGO clinical trial, funded by LifeArc and PSC Support, which explores a…